Transaction DateRecipientSharesTypePriceValue
11th December 2020David R Epstein1,000Open or private purchase$6.91$6,910.00
11th December 2020David R Epstein800Open or private purchase$7.16$5,728.00
11th December 2020David R Epstein200Open or private purchase$7.02$1,404.00
11th December 2020David R Epstein500Open or private purchase$6.98$3,490.00
11th December 2020David R Epstein200Open or private purchase$6.40$1,280.00
11th December 2020David R Epstein4,970Open or private purchase$6.49$32,255.30
11th December 2020David R Epstein30Open or private purchase$6.45$193.50
23rd November 2020Ventures Fund Iv General Partner Llc Flagship966,234Other acquisition or disposition$0.00
23rd November 2020Ventures Fund Iv General Partner Llc Flagship1,186,310Other acquisition or disposition$0.00
23rd November 2020Ventures Fund Iv General Partner Llc Flagship642,180Other acquisition or disposition$0.00
Axcella Health
Axcella Health logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.


Axcella Health, Inc. engages in the research and development of novel multifactorial interventions to support health. The company was founded by Noubar B. Afeyan, Geoffrey von Maltzahn, and David A. Berry on August 27, 2008.


Ticker: AXLA
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1633070
Employees: 64
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Assets, Current: $124 M (32%)
Property, Plant and Equipment, Net: $357 Th (0%)
Assets: $125 M (31%)
Long-term Debt, Current Maturities: $5 M (0%)
Accounts Payable, Current: $2 M (-18%)
Accrued Liabilities, Current: $4 M (0%)
Liabilities, Current: $11 M (31%)
Other Liabilities, Noncurrent: $945 Th (7%)
Liabilities: $32 M (-7%)
Common Stock, Value, Issued: $37 Th (54%)
Common Stock, Shares, Issued: $37 M (55%)
Retained Earnings (Accumulated Deficit): $245 M (0%)
Treasury Stock, Shares: $4 M (0%)
Stockholders' Equity (Parent): $93 M (0%)
Liabilities and Equity: $125 M (31%)
Research and Development: $9 M (-54%)
General and Administrative Expenses: $5 M (-47%)
Operating Income/Loss: $13 M (-52%)
Other Income, net: $708 Th (-43%)